?
Brookwell Limited
Portfolio analysis at 31 December 2012
Details of the investments held in the D Share portfolio at 31 December 2012 are set out below.
Investee company | Number of | Current | Current | Percentage |
shares held | value per | value | of portfolio | |
share | ||||
pence | £'000 | |||
Northern Investors Company | 791,283 | 293.00 | 2,319 | 67.3% |
Universe Group | 9,150,000 | 3.50 | 320 | 9.3% |
Metalrax Group | 6,835,040 | 4.25 | 291 | 8.4% |
Private & Commercial Finance Group | 4,696,200 | 5.75 | 270 | 7.8% |
Squarestone Brasil 1 | 700,000 | 23.87 | 167 | 4.8% |
Evocutis | 9,779,860 | 0.70 | 69 | 2.0% |
Hotel Corporation | 722,071 | 1.30 | 9 | 0.3% |
Union Medtech | 156,250 | 1.25 | 2 | 0.1% |
ESV Group | 20,000 | 2.00 | 0 | 0.0% |
Orchid Developments 1 | 6,565,447 | - | - | 0.0% |
Total portfolio investments | 3,447 | 100.0% | ||
Other net assets | 469 | |||
Net assets | 3,916 |
Notes
1 These investments are suspended/delisted.
2 The above table excludes the Company's holdings in Trans Balkan Investments and in warrants issued by Squarestone Brasil, both of which are delisted and carried at nil.
For further information please contact:
Brookwell Limited
Tom Lancaster-King Tel: 01481 726 034
Progressive AIM Realisation Limited (Investment manager)
Robert Legget Tel: 020 7566 5550
Deloitte Corporate Finance (Nominated adviser)
James Lewis / Paul Zimmerman Tel: 020 7936 3000
Marshall Securities Limited (Broker)
John Webb Tel: 020 7490 3788
9 January 2013
Website: www.brookwelllimited.com
This information is provided by RNS
distributed by
|